ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 79 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $66,000 | -13.2% | 13,460 | -6.3% | 0.00% | 0.0% |
| Q2 2021 | $76,000 | +72.7% | 14,360 | +133.6% | 0.00% | 0.0% |
| Q1 2019 | $44,000 | +57.1% | 6,148 | +372.9% | 0.00% | -50.0% |
| Q3 2017 | $28,000 | -52.5% | 1,300 | -61.8% | 0.00% | -50.0% |
| Q2 2017 | $59,000 | +2850.0% | 3,400 | +2228.8% | 0.00% | – |
| Q3 2016 | $2,000 | -89.5% | 146 | -88.1% | 0.00% | -100.0% |
| Q2 2016 | $19,000 | -95.6% | 1,227 | -92.5% | 0.00% | -95.2% |
| Q2 2015 | $429,000 | +42.1% | 16,365 | -6.0% | 0.02% | +31.2% |
| Q4 2014 | $302,000 | – | 17,415 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
| Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
| ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
| DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
| Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
| Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
| Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
| Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
| EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |